Global Health
RSSArticles
-
Monkeypox Spread to 29 Non-Endemic Nations Unprecedented
The near-simultaneous emergence of monkeypox in the United States, Europe, and other regions where it rarely is seen has raised questions whether the virus could become endemic beyond West and Central Africa, where it is common.
-
WHO Updates Guidance on Long-Acting HIV Prophylaxis
International group suggests adding injectable cabotegravir to list of prevention tools.
-
SARS-CoV-2 as a North American Zoonosis
COVID-19 has become a North American zoonosis endemic in the Northeastern white-tailed deer population. Whether it causes symptomatic infection is unclear, but most infections likely are subclinical, with viral shedding in nasal secretions and feces. Now that infection has become established in this animal group, it likely will spread easily.
-
Are Boosters Prolonging the Pandemic?
Some people have raised the question of whether booster shots are unethical from a global perspective, and even counterproductive to ending the pandemic because highly mutated variants will continue to arise in unvaccinated patients. -
Pediatric Malaria
Malaria is present in all continents except Antarctica and has led to significant human illness and death. Children account for the majority of malaria deaths globally, making malaria a significant contributor to childhood mortality worldwide. Malaria is a mandatory consideration for children with fever who are returned travelers, since the disease process can lead to significant mortality and rapid clinical decline. The authors provide an update and current state of care for malaria in the pediatric population. -
Vaccines Are Available, but the Search for COVID-19 Therapeutics Continues
Right after the FDA issued an emergency use authorization for one drug, feds pressed pause on distributing another. -
Controversy Developing Over Vaccine Passports
Concerns are emerging about individual rights, equal access, and how anyone would enforce mandates.
-
U.S. Supports Waiving Intellectual Property Protections for COVID-19 Vaccines
The aim is to accelerate the spread of shots around the globe.
-
Coalition Calls for More Federal Investment in Antimicrobial Resistance Prevention
Groups ask Congress for additional money for research, innovation, surveillance, and stewardship.
-
Rifampin vs. Isoniazid for Latent Tuberculosis
A health system cost comparison showed that four months of rifampin was safer and less expensive than nine months of isoniazid in high-income countries, medium-income countries, and African countries.